查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1823783

全球定量吸入器市場：產業分析、規模、佔有率、成長、趨勢與預測，2025-2032

Metered Dose Inhalers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 182 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球定量吸入器市場的綜合報告，詳細分析了重要市場動態，包括成長動力、新興趨勢、市場促進因素和挑戰。本報告深入分析了市場格局，幫助相關人員做出明智的決策。

關鍵見解

  • 定量吸入器市場規模（2025年）：303億美元
  • 預計市場規模（2032年）：410億美元
  • 全球市場成長率（2025-2032年年複合成長率）：4.4%

定量吸入器市場：研究範圍

定量吸入器（MDI）市場涵蓋用於治療氣喘和慢性阻塞性肺病（COPD）等呼吸系統疾病的精準劑量吸入裝置。這類吸入器因其便攜性、易用性以及能夠高效地將藥物直接輸送至肺部而得到廣泛應用。呼吸系統疾病的盛行率不斷上升、吸入器技術的進步以及人們對吸入療法益處的日益認知推動了該市場的發展。

市場促進因素：

全球定量吸入器市場的成長受到多種關鍵因素的推動，其中包括因污染、吸煙和生活方式改變而導致的氣喘、慢性阻塞性肺病和其他呼吸系統疾病病例的增加。吸入器設計的技術進步，例如呼吸驅動的定量吸入器（MDI）和具有數位監控的智慧吸入器，提高患者的依從性和治療效果。此外，老年人口的成長和醫療保健支出的增加也刺激了對定量吸入器的需求。新興國家醫療基礎設施的不斷擴張也進一步促進了市場的成長。

市場限制：

儘管成長前景強勁，計量吸入器市場仍面臨諸多挑戰，例如吸入器設備高成本、監管障礙以及對計量吸入器所用推進劑的環境影響的擔憂。患者對正確吸入技術的認知度低也可能影響治療效果。此外，市場可能面臨政府對吸入器配方的嚴格監管以及對傳統氫氟烷烴（HFA）推進劑永續替代品的需求等挑戰。

市場機會：

定量吸入器市場蘊含著巨大的成長機會，包括開發環保吸入器以取代傳統推進劑，以及整合智慧技術以增強藥物追蹤。新興國家醫療基礎設施投資的不斷增加，以及居家照護解決方案的日益普及，也為市場擴張提供了更多機會。此外，製藥公司與醫療服務提供者之間的策略聯盟可以促進創新，並改善患者獲得先進吸入療法的管道。

本報告探討的關鍵問題

  • 推動全球定量吸入器市場成長的主要因素有哪些？
  • 哪些地區和細分市場對定量吸入器的需求最高？
  • 技術進步如何影響定量吸入器市場的競爭格局？
  • 定量吸入器市場的主要企業是誰？他們採取什麼策略來維持市場領先地位？
  • 定量吸入器市場有哪些新興趨勢和未來前景？

目錄

第1章 全球定量吸入器市場展望

第2章 全球定量吸入器市場展望：依服務

  • 引言/主要發現
  • 2019-2024年歷史市場規模與分析：依服務
  • 2025-2032年市場目前規模、分析及預測：依服務
  • 未來市場預測
  • 高級市場洞察
  • 產業趨勢和重大市場事件
  • PMR分析與建議

第3章 市場概況

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長展望
  • COVID-19影響分析
  • 預測因子 - 相關性和影響力

第4章 增值洞察

  • 監管狀況
  • 產品採用分析
  • 價值鏈分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第5章 全球定量吸入器市場展望：

  • 主要亮點
    • 市場規模及年成長率
    • 絕對的商機
  • 市場規模分析及預測
    • 2019-2024年歷史市場規模分析
    • 2025-2032年目前市場規模分析與預測
  • 全球定量吸入器市場展望：依類型
    • 引言/主要發現
    • 2019-2024年歷史市場規模分析：依類型
    • 2025-2032年市場規模分析及預測：依類型
      • 緩解吸入器
      • 長效支氣管擴張劑吸入器
    • 市場吸引力分析：依類型
  • 全球定量吸入器市場前景：依最終用戶
    • 引言/主要發現
    • 2019-2024年歷史市場規模分析：依最終用戶
    • 2025-2032年當前市場規模分析和預測：依最終用戶
      • 居家照護
      • 醫院
      • 診所
    • 市場吸引力分析：依最終用戶

第6章 全球定量吸入器市場展望：依地區

  • 主要亮點
  • 2019-2024年歷史市場規模分析：依地區
  • 2025-2032年當前市場規模分析及預測：依地區
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：依地區

第7章 北美定量吸入器市場展望

第8章 歐洲定量吸入器市場展望

第9章 東亞定量吸入器市場展望

第10章 南亞和大洋洲定量吸入器市場展望

第11章 拉丁美洲定量吸入器市場展望

第12章 中東和非洲定量吸入器市場展望

第13章 競爭格局

  • 2024年市場佔有率分析
  • 市場類型
    • 各市場競爭強度圖
    • 競爭儀表板
  • 公司簡介（詳情 - 概述、財務狀況、策略、最新發展）
    • Cipla Inc.
    • Presspart Manufacturing Ltd.
    • Midascare Pharmaceuticals Pvt. Ltd.
    • Beximco Pharma Ltd.
    • GlaxoSmithKline Pharmaceuticals Ltd.
    • 3M Pharmaceuticals Pty Ltd.
    • Biocare Manufacturing Sdn Bhd.
    • Anomatic Innovation &Design Center &Manufacturing
    • Aristo Pharma Ltd.

第14章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP33723

Persistence Market Research has recently released a comprehensive report on the global Metered Dose Inhalers Market, providing an in-depth analysis of key market dynamics, including growth drivers, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Metered Dose Inhalers Market Size (2025E): USD 30.3 Bn
  • Projected Market Value (2032F): USD 41 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.4%

Metered Dose Inhalers Market - Report Scope:

The Metered Dose Inhalers (MDI) Market comprises inhalation devices that deliver precise doses of medication for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These inhalers are widely used due to their portability, ease of use, and effectiveness in delivering medication directly to the lungs. The market is driven by the increasing prevalence of respiratory diseases, advancements in inhaler technology, and growing awareness of inhalation therapy benefits.

Market Growth Drivers:

Several key factors are driving the growth of the global Metered Dose Inhalers Market, including rising cases of asthma, COPD, and other respiratory conditions due to pollution, smoking, and lifestyle changes. Technological advancements in inhaler design, such as breath-actuated MDIs and smart inhalers with digital monitoring, are enhancing patient compliance and treatment outcomes. Additionally, the growing geriatric population and increased healthcare expenditure are fueling demand for MDIs. Expanding healthcare infrastructure in emerging economies further contributes to market growth.

Market Restraints:

Despite strong growth prospects, the Metered Dose Inhalers Market faces challenges such as the high cost of inhaler devices, regulatory hurdles, and concerns over the environmental impact of propellants used in MDIs. Limited patient awareness about correct inhaler techniques can also impact treatment efficacy. The market may experience challenges related to stringent government regulations regarding inhaler formulations and the need for sustainable alternatives to traditional hydrofluoroalkane (HFA) propellants.

Market Opportunities:

The Metered Dose Inhalers Market presents substantial growth opportunities, including the development of eco-friendly inhalers to replace traditional propellants and the integration of smart technology for enhanced medication tracking. Increasing investments in healthcare infrastructure in emerging economies and the rising adoption of homecare solutions provide further market expansion opportunities. Additionally, strategic collaborations between pharmaceutical companies and healthcare providers can drive innovation and improve patient access to advanced inhalation therapies.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the Metered Dose Inhalers Market?
  • Which regions and market segments are witnessing the highest demand for metered dose inhalers?
  • How are technological advancements influencing the competitive landscape of the Metered Dose Inhalers Market?
  • Who are the key players in the Metered Dose Inhalers Market, and what strategies are they employing to sustain market leadership?
  • What are the emerging trends and future outlooks for the Metered Dose Inhalers Market?

Competitive Intelligence and Business Strategy:

Leading companies in the Metered Dose Inhalers Market, such as Cipla Inc., Presspart Manufacturing Ltd., and GlaxoSmithKline Pharmaceuticals Ltd., are focusing on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies are investing in the development of next-generation inhalers, including breath-actuated and digitally connected devices, to improve patient compliance and treatment efficiency. Collaborations with healthcare providers, digital health platforms, and regulatory agencies are key strategies to expand market reach and enhance patient outcomes. Sustainability initiatives, such as developing low-carbon-footprint propellants, are also gaining importance in the market.

Key Companies Profiled:

  • Cipla Inc.
  • Presspart Manufacturing Ltd.
  • Midascare Pharmaceuticals Pvt. Ltd.
  • Beximco Pharma Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • 3M Pharmaceuticals Pty Ltd.
  • Biocare Manufacturing Sdn Bhd.
  • Anomatic Innovation & Design Center & Manufacturing
  • Aristo Pharma Ltd.

Metered Dose Inhalers Market Segmentation:

By Type:

  • Reliever Inhaler
  • Long-acting Bronchodilators Inhaler

By End User:

  • Homecare
  • Hospitals
  • Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Global Metered Dose Inhalers Market Outlook

2. Global Metered Dose Inhalers Market Outlook: Services

  • 2.1. Introduction/Key Findings
  • 2.2. Historical Market Size (US$ Bn ) and Analysis, By Services, 2019-2024
  • 2.3. Current Market Size (US$ Bn ) and Analysis and Forecast, By Services, 2025-2032
  • 2.4. Future Market Projections
  • 2.5. Premium Market Insights
  • 2.6. Industry Developments and Key Market Events
  • 2.7. PMR Analysis and Recommendations

3. Market Overview

  • 3.1. Market Scope and Definition
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunity
    • 3.2.4. Challenges
    • 3.2.5. Key Trends
  • 3.3. Macro-Economic Factors
    • 3.3.1. Global Sectorial Outlook
    • 3.3.2. Global GDP Growth Outlook
  • 3.4. COVID-19 Impact Analysis
  • 3.5. Forecast Factors - Relevance and Impact

4. Value Added Insights

  • 4.1. Regulatory Landscape
  • 4.2. Product Adoption Analysis
  • 4.3. Value Chain Analysis
  • 4.4. Key Deals and Mergers
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Five Force Analysis

5. Global Metered Dose Inhalers Market Outlook:

  • 5.1. Key Highlights
    • 5.1.1. Market Size (US$ Bn ) and Y-o-Y Growth
    • 5.1.2. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn ) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn ) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn ) Analysis and Forecast, 2025-2032
  • 5.3. Global Metered Dose Inhalers Market Outlook: Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn ) Analysis, By Type, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
      • 5.3.3.1. Reliever Inhaler
      • 5.3.3.2. Long-acting bronchodilators Inhaler
    • 5.3.4. Market Attractiveness Analysis: Type
  • 5.4. Global Metered Dose Inhalers Market Outlook: End User
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn ) Analysis, By End User, 2019-2024
    • 5.4.3. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
      • 5.4.3.1. Homecare
      • 5.4.3.2. Hospitals
      • 5.4.3.3. Clinics
    • 5.4.4. Market Attractiveness Analysis: End User

6. Global Metered Dose Inhalers Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Metered Dose Inhalers Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Type
    • 7.2.3. By End User
  • 7.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 7.4.1. Reliever Inhaler
    • 7.4.2. Long-acting bronchodilators Inhaler
  • 7.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 7.5.1. Homecare
    • 7.5.2. Hospitals
    • 7.5.3. Clinics
  • 7.6. Market Attractiveness Analysis

8. Europe Metered Dose Inhalers Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Type
    • 8.2.3. By End User
  • 8.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 8.4.1. Reliever Inhaler
    • 8.4.2. Long-acting bronchodilators Inhaler
  • 8.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 8.5.1. Homecare
    • 8.5.2. Hospitals
    • 8.5.3. Clinics
  • 8.6. Market Attractiveness Analysis

9. East Asia Metered Dose Inhalers Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Type
    • 9.2.3. By End User
  • 9.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 9.4.1. Reliever Inhaler
    • 9.4.2. Long-acting bronchodilators Inhaler
  • 9.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 9.5.1. Homecare
    • 9.5.2. Hospitals
    • 9.5.3. Clinics
  • 9.6. Market Attractiveness Analysis

10. South Asia & Oceania Metered Dose Inhalers Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Type
    • 10.2.3. By End User
  • 10.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 10.4.1. Reliever Inhaler
    • 10.4.2. Long-acting bronchodilators Inhaler
  • 10.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 10.5.1. Homecare
    • 10.5.2. Hospitals
    • 10.5.3. Clinics
  • 10.6. Market Attractiveness Analysis

11. Latin America Metered Dose Inhalers Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Type
    • 11.2.3. By End User
  • 11.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 11.4.1. Reliever Inhaler
    • 11.4.2. Long-acting bronchodilators Inhaler
  • 11.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 11.5.1. Homecare
    • 11.5.2. Hospitals
    • 11.5.3. Clinics
  • 11.6. Market Attractiveness Analysis

12. Middle East & Africa Metered Dose Inhalers Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Type
    • 12.2.3. By End User
  • 12.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 12.4.1. Reliever Inhaler
    • 12.4.2. Long-acting bronchodilators Inhaler
  • 12.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 12.5.1. Homecare
    • 12.5.2. Hospitals
    • 12.5.3. Clinics
  • 12.6. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Type
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Cipla Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Presspart Manufacturing Ltd.
    • 13.3.3. Midascare Pharmaceuticals Pvt. Ltd.
    • 13.3.4. Beximco Pharma Ltd.
    • 13.3.5. GlaxoSmithKline Pharmaceuticals Ltd.
    • 13.3.6. 3M Pharmaceuticals Pty Ltd.
    • 13.3.7. Biocare Manufacturing Sdn Bhd.
    • 13.3.8. Anomatic Innovation & Design Center & Manufacturing
    • 13.3.9. Aristo Pharma Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations